Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

NCT06655896 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Scleroderma, Diffuse

Interventions

BIOLOGICAL: rapcabtagene autoleucel
BIOLOGICAL: rituximab

Sponsor

Novartis Pharmaceuticals